VANDERBILT-INGRAM CANCER CENTER received an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant.
The CCSG provides almost $30 million over five years to support scientific leadership and administration of the cancer center, as well as infrastructure that includes shared resources for cancer investigators.
Despite tight federal budgets, VICC will receive an increase over the previous five-year grant award.
This is the third renewal of VICC as an NCI-designated Comprehensive Cancer Center. It is one of only 45 such centers in the United States and the only Comprehensive Cancer Center in Tennessee providing treatment for both adult and pediatric patients.
VICC is among the few centers in the United States with multiple NCI-designated Specialized Program of Research Excellence (SPORE) grant programs, including breast and gastrointestinal cancer.
VICC has nearly 300 faculty members and generates more than $140 million in annual federal research funding, ranking it among the top 10 centers in the country in competitive grant support. The clinical program sees more than 6,000 new cancer patients each year.
THEUNCLINEBERGER COMPREHENSIVE CANCER CENTER earned an “exceptional” rating from the NCI for a major grant application associated with the center’s multidisciplinary research.
The rating was given to UNC Lineberger’s application to the NCI for renewal of a five-year grant that supports multidisciplinary research and shared scientific core resources for hundreds of scientists and clinicians in addition to other key center functions.
“This recognition speaks to the excellence of our researchers’ work in a wide range of disciplines, from clinical research to cancer genetics to breast cancer and molecular therapeutics,” Norman Sharpless, director of UNC Lineberger and the Wellcome Distinguished Professor in Cancer Research, said in a statement. “We are striving to leverage this high-impact research to ultimately reduce cancer incidence and mortality across North Carolina.”
The rating followed a rigorous institutional review with a site visit by a panel of 22 peer reviewers. UNC Lineberger researchers made presentations to demonstrate both the depth and breadth of their work spanning the basic sciences, population sciences, clinical sciences and translational research.
UNC Lineberger researchers made presentations to demonstrate both the depth and breadth of their work spanning the basic sciences, population sciences, clinical sciences and translational research.
Researchers presented in each of nine program areas: cancer cell biology, immunology research, molecular therapeutics, virology, cancer genetics, clinical and translational research, breast cancer, cancer prevention and control, and cancer epidemiology.
